|
1.
|
RC JiLymphatic endothelial cells, tumor
lymphangiogenesis and metastasis: New insight into intratumoral and
peritumoral lymphaticsCancer Metastasis Rev25677694200617160713
|
|
2.
|
Y CaoW ZhongTumor-derived lymphangiogenic
factors and lymphatic metastasisBiomed
Pharmacother61534539200710.1016/j.biopha.2007.08.00917904785
|
|
3.
|
M RaicaD RibattiTargeting tumor
lymphangiogenesis: an updateCurr Med
Chem17698708201010.2174/09298671079051447120088760
|
|
4.
|
T TammelaK AlitaloLymphangiogenesis:
Molecular mechanisms and future
promiseCell140460476201020178740
|
|
5.
|
MJ KarkkainenP HaikoK SainioJ PartanenJ
TaipaleTV PetrovaM JeltschDG JacksonM TalikkaH RauvalaVascular
endothelial growth factor C is required for sprouting of the first
lymphatic vessels from embryonic veinsNat
Immunol57480200410.1038/ni101314634646
|
|
6.
|
H RoyS BhardwajS Ylä-HerttualaBiology of
vascular endothelial growth factorsFEBS
Lett58028792887200616631753
|
|
7.
|
T HlaD Bishop-BaileyCH LiuHJ SchaefersOC
TrifanCyclooxygenase-1 and cyclooxygenase-2 isoenzymesInt J Biochem
Cell Biol31551557199910.1016/S1357-2725(98)00152-6
|
|
8.
|
WL SmithRM GaravitoDL DeWittProstaglandin
endoperoxide H synthases (cyclooxygenases)-1 and -2J Biol
Chem2713315733160199610.1074/jbc.271.52.331578969167
|
|
9.
|
N GhoshR ChakiV MandalS MandalCox-2 as a
target for cancer chemotherapyPharmacol
Rep62233244201010.1016/S1734-1140(10)70262-020508278
|
|
10.
|
RN BhattacharjeeAV TimoshenkoJ CaiPK
LalaRelationship between cyclooxygenase-2 and human epidermal
growth factor receptor 2 in vascular endothelial growth factor C
up-regulation and lymphangiogenesis in human breast cancerCancer
Sci10120262032201010.1111/j.1349-7006.2010.01647.x
|
|
11.
|
J ZhangJ JiF YuanL ZhuC YanYY YuBY LiuZG
ZhuYZ LinCyclooxygenase-2 expression is associated with VEGF-C and
lymph node metastases in gastric cancer patientsBiomed
Pharmacother59Suppl
2S285S288200510.1016/S0753-3322(05)80047-216507394
|
|
12.
|
JM DiJ ZhouXL ZhouX GaoCQ ShaoJ PangQP
SunY ZhangXX RuanCyclooxygenase-2 expression is associated with
vascular endothelial growth factor-C and lymph node metastasis in
human prostate cancerArch Med
Res40268275200910.1016/j.arcmed.2009.03.00219608016
|
|
13.
|
X GuoY ChenZ XuZ XuY QianX YuPrognostic
significance of VEGF-C expression in correlation with COX-2,
lymphatic microvessel density, and clinicopathologic
characteristics in human non-small cell lung cancerActa Biochim
Biophys Sin (Shanghai)41217222200910.1093/abbs/gmp00419280060
|
|
14.
|
N WeidnerJP SempleWR WelchJ FolkmanTumor
angiogenesis and metastasis - correlation in invasive breast
carcinomaN Engl J
Med32418199110.1056/NEJM1991010332401011701519
|
|
15.
|
I KadowakiR IchinohasamaH HarigaeK
IshizawaY OkitsuJ KameokaT SasakiAccelerated lymphangiogenesis in
malignant lymphoma: possible role of VEGF-A and VEGF-CBr J
Haematol130869877200510.1111/j.1365-2141.2005.05695.x16156857
|
|
16.
|
T WróelG MazurP DziegielM JeleńA SzubaK
KuliczkowskiM ZabelDensity of intranodal lymphatics and VEGF-C
expression in B-cell lymphoma and reactive lymph nodesFolia
Histochem Cytobiol444347200616584091
|
|
17.
|
TC MineoV AmbrogiA BaldiC RabittiP
BolleroB VincenziG ToniniPrognostic impact of VEGF, CD31, CD34, and
CD105 expression and tumor vessel invasion after radical surgery
for IB-IIA non-small cell lung cancerJ Clin
Pathol57591597200410.1136/jcp.2003.01350815166262
|
|
18.
|
M LinSP MaHZ LinP JiD XieJX YuIntratumoral
as well as peritumoral lymphatic vessel invasion correlates with
lymph node metastasis and unfavorable outcome in colorectal
cancerClin Exp
Metastasis27123132201010.1007/s10585-010-9309-020195706
|
|
19.
|
EC CitakA OguzC KaradenizN
AkyurekImmunohistochemical expression of angiogenic cytokines in
childhood Hodgkin lymphomaPathol Res
Pract2048996200810.1016/j.prp.2007.11.00518207652
|
|
20.
|
D GratzingerS ZhaoRJ MarinelliAV KappRJ
TibshiraniAS HammerS Hamilton-DutoitY NatkunamMicrovessel density
and expression of vascular endothelial growth factor and its
receptors in diffuse large B-cell lymphoma subtypesAm J
Pathol17013621369200710.2353/ajpath.2007.06090117392174
|
|
21.
|
T HolopainenM BryK AlitaloA
SaaristoPerspective on lymphangiogenesis and angiogenesis in
cancerJ Surg Oncol103484488201110.1002/jso.2180821480240
|
|
22.
|
B DetryF BruyèreC ErpicumJ PaupertF
LamayeC MaillardB LenoirJ FoidartM ThiryA NoëlDigging deeper into
lymphatic vessel formation in vitro and in vivoBMC Cell
Biol122939201110.1186/1471-2121-12-2921702933
|
|
23.
|
A Longatto-FilhoC PinheiroSM PereiraD
EtlingerMA MoreiraLF JubéGS QueirozF BaltazarFC SchmittLymphatic
vessel density and epithelial D2-40 immunoreactivity in
pre-invasive and invasive lesions of the uterine cervixGynecol
Oncol1074551200710.1016/j.ygyno.2007.05.02917604828
|
|
24.
|
HF GouXC ChenJ ZhuM JiangY YangD CaoM
HouExpression of COX-2 and VFGF-C in gastric cancer: correlations
with lymphangiogenesis and prognostic implicationsJ Exp Clin Cancer
Res301421201110.1186/1756-9966-30-1421272377
|
|
25.
|
V MumprechtM DetmarLymphangiogenesis and
cancer metastasisJ Cell Mol
Med1314051416200910.1111/j.1582-4934.2009.00834.x19583813
|
|
26.
|
S PaydasM ErginG SeydaogluS ErdoganS
YavuzPrognostic significance of angiogenic/lymphangiogenic,
anti-apoptotic, inflammatory and viral factors in 88 cases with
diffuse large B cell lymphoma and review of the literatureLeuk
Res3316271635200910.1016/j.leukres.2009.02.015
|
|
27.
|
S PaydasG SeydaogluM ErginS ErdoganS
YavuzThe prognostic significance of VEGF-C and VEGF-A in
non-Hodgkin lymphomasLeuk
Lymphoma50366373200910.1080/1042819080270666519347725
|
|
28.
|
I PazgalO BoycovO ShpilbergE OkonO
BaireyExpression of VEGF-C, VEGF-D and their receptor VEGFR-3 in
diffuse large B-cell lymphomasLeuk
Lymphoma4822132220200710.1080/1042819070163282217926187
|
|
29.
|
KN GanjooAM MooreA OraziJA SenCS JohnsonCS
AnThe importance of angiogenesis markers in the outcome of patients
with diffuse large B cell lymphoma: a retrospective study of 97
patientsJ Cancer Res Clin
Oncol134381387200810.1007/s00432-007-0294-x17694324
|
|
30.
|
S PaydasM ErginS ErdoganG
SeydaogluCyclooxygenase-2 expression in non-Hodgkin’s lymphomasLeuk
Lymphoma483893952007
|
|
31.
|
B HazarM ErginE SeyrekS ErdoğanI TuncerS
HakverdiCyclooxygenase-2 (Cox-2) expression in lymphomasLeuk
Lymphoma4513951399200410.1080/1042819031000165403215359639
|
|
32.
|
BHA Von RahdenHJ SteinF PuhringerI KochR
LangerG PiontekJR SiewertH HoflerM SarbiaCoexpression of
cyclooxygenases (COX-1, COX-2) and vascular endothelial growth
factors (VEGF-A, VEGF-C) in esophageal adenocarcinomaCancer
Res6550385044200515958546
|
|
33.
|
JS ByeonHY JungYJ LeeD LeeGH LeeSJ MyungSK
YangWS HongJH KimYI MinJS KimClinicopathological significance of
vascular endothelial growth factor-C and cyclooxygenase-2 in
esophageal squamous cell carcinomaJ Gastroenterol
Hepatol19648654200410.1111/j.1440-1746.2004.03348.x15151619
|
|
34.
|
PA KyzasD StefanouNJ AgnantisCOX-2
expression correlates with VEGF-C and lymph node metastases in
patients with head and neck squamous cell carcinomaMod
Pathol18153160200510.1038/modpathol.380024415272284
|
|
35.
|
JL SuJY ShihML YenYM JengCC ChangCY
HsiehLH WeiPC YangML KuoCyclooxygenase-2 induces EP1- and
HER-2/Neu-dependent vascular endothelial growth factor-C
up-regulation: a novel mechanism of lymphangiogenesis in lung
adenocarcinomaCancer
Res64554564200410.1158/0008-5472.CAN-03-130114744769
|
|
36.
|
AV TimoshenkoC ChakrabortyGF WagnerPK
LalaCOX-2-mediated stimulation of the lymphangiogenic factor VEGF-C
in human breast cancerBr J
Cancer9411541163200610.1038/sj.bjc.660306716570043
|
